Kerry Group, a taste and nutrition company, completed the acquisition of Biosearch, a designer, developer and manufacturer of sophisticated oligonucleotide-based tools, for £109m. "We have significantly advanced our capabilities in proactive nutrition in recent years. Biosearch is a strong complement to our portfolio and brings leading clinical research capabilities and functional food technologies across multiple life stages and need states. We share a commitment to advance the science behind healthier food and I would like to extend a warm welcome to the Biosearch team,” Edmond Scanlon, Kerry Group CEO.